RU2657828C2 - Фармацевтическая композиция, содержащая обогащенную тромбоцитами плазму и предназначенная для предотвращения или лечения нейросенсорной тугоухости или шума в ушах, и способ ее применения - Google Patents

Фармацевтическая композиция, содержащая обогащенную тромбоцитами плазму и предназначенная для предотвращения или лечения нейросенсорной тугоухости или шума в ушах, и способ ее применения Download PDF

Info

Publication number
RU2657828C2
RU2657828C2 RU2016134793A RU2016134793A RU2657828C2 RU 2657828 C2 RU2657828 C2 RU 2657828C2 RU 2016134793 A RU2016134793 A RU 2016134793A RU 2016134793 A RU2016134793 A RU 2016134793A RU 2657828 C2 RU2657828 C2 RU 2657828C2
Authority
RU
Russia
Prior art keywords
prp
hearing loss
subject
pharmaceutical composition
blood
Prior art date
Application number
RU2016134793A
Other languages
English (en)
Russian (ru)
Other versions
RU2016134793A3 (ko
RU2016134793A (ru
Inventor
Мин По СИМ
Original Assignee
Мин По СИМ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мин По СИМ filed Critical Мин По СИМ
Publication of RU2016134793A3 publication Critical patent/RU2016134793A3/ru
Publication of RU2016134793A publication Critical patent/RU2016134793A/ru
Application granted granted Critical
Publication of RU2657828C2 publication Critical patent/RU2657828C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2016134793A 2015-08-27 2016-08-26 Фармацевтическая композиция, содержащая обогащенную тромбоцитами плазму и предназначенная для предотвращения или лечения нейросенсорной тугоухости или шума в ушах, и способ ее применения RU2657828C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2015-0121038 2015-08-27
KR20150121038 2015-08-27
KR1020160057806A KR101738815B1 (ko) 2015-08-27 2016-05-11 혈소판 풍부 혈장을 포함하는 감각신경성 난청 또는 이명을 예방 또는 치료하기 위한 약학적 조성물 및 이를 이용한 방법
KR10-2016-0057806 2016-05-11

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2018110570A Division RU2720511C2 (ru) 2015-08-27 2016-08-26 Фармацевтическая композиция, содержащая обогащенную тромбоцитами плазму и предназначенная для предотвращения или лечения нейросенсорной тугоухости или шума в ушах, и способ ее применения

Publications (3)

Publication Number Publication Date
RU2016134793A3 RU2016134793A3 (ko) 2018-03-01
RU2016134793A RU2016134793A (ru) 2018-03-01
RU2657828C2 true RU2657828C2 (ru) 2018-06-15

Family

ID=58404034

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2016134793A RU2657828C2 (ru) 2015-08-27 2016-08-26 Фармацевтическая композиция, содержащая обогащенную тромбоцитами плазму и предназначенная для предотвращения или лечения нейросенсорной тугоухости или шума в ушах, и способ ее применения
RU2018110570A RU2720511C2 (ru) 2015-08-27 2016-08-26 Фармацевтическая композиция, содержащая обогащенную тромбоцитами плазму и предназначенная для предотвращения или лечения нейросенсорной тугоухости или шума в ушах, и способ ее применения

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2018110570A RU2720511C2 (ru) 2015-08-27 2016-08-26 Фармацевтическая композиция, содержащая обогащенную тромбоцитами плазму и предназначенная для предотвращения или лечения нейросенсорной тугоухости или шума в ушах, и способ ее применения

Country Status (3)

Country Link
KR (1) KR101738815B1 (ko)
HK (1) HK1232154A1 (ko)
RU (2) RU2657828C2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190019707A (ko) 2017-08-18 2019-02-27 한림대학교 산학협력단 프로테오믹스 기법을 이용한 혈소판 풍부 혈장 내의 조직치유 관련 단백질 분류방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2319508C2 (ru) * 2003-07-31 2008-03-20 ФАРМАЦИЯ ЭНД АПДЖОН КОМПАНИ ЭлЭлСи Диспергируемый препарат противовоспалительного агента
WO2012092458A2 (en) * 2010-12-30 2012-07-05 Anthrogenesis Corporation Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
WO2014179834A1 (en) * 2013-05-10 2014-11-13 Cell-Innovations Pty Ltd Compositions and methods for the treatment of tinnitus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008109703A (ru) * 2008-03-11 2009-09-20 Федор Вячеславович Семенов (RU) Способ герметизации предверия лабиринта в барабанной полости поршневой стапедопластике

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2319508C2 (ru) * 2003-07-31 2008-03-20 ФАРМАЦИЯ ЭНД АПДЖОН КОМПАНИ ЭлЭлСи Диспергируемый препарат противовоспалительного агента
WO2012092458A2 (en) * 2010-12-30 2012-07-05 Anthrogenesis Corporation Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
WO2014179834A1 (en) * 2013-05-10 2014-11-13 Cell-Innovations Pty Ltd Compositions and methods for the treatment of tinnitus

Also Published As

Publication number Publication date
RU2016134793A3 (ko) 2018-03-01
HK1232154A1 (zh) 2018-01-05
KR20170026092A (ko) 2017-03-08
RU2720511C2 (ru) 2020-04-30
KR101738815B1 (ko) 2017-05-23
RU2018110570A (ru) 2019-02-28
RU2018110570A3 (ko) 2019-02-28
RU2016134793A (ru) 2018-03-01

Similar Documents

Publication Publication Date Title
Lefebvre et al. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study
Levine et al. Tinnitus
Karmody et al. Deafness in congenital syphilis
Ballantyne Iatrogenic deafness
Tassinari et al. Ménière's disease treatment: a patient-centered systematic review
US10561684B2 (en) Pharmaceutical composition for preventing or treating sensorineural hearing loss or tinnitus including platelet-rich plasma and method using the same
Sohmer et al. Semicircular canal fenestration–improvement of bone-but not air-conducted auditory thresholds
Goodhill Sudden Sensorineural Deafness: Labyrinthine Membrane Ruptures in Sudden Sensorineural Hearing Loss
King et al. Gentamicin applied to the oval window suppresses vestibular function in guinea pigs
Mulherin et al. Aminoglycoside induced ototoxicity in patients with cystic fibrosis
RU2657828C2 (ru) Фармацевтическая композиция, содержащая обогащенную тромбоцитами плазму и предназначенная для предотвращения или лечения нейросенсорной тугоухости или шума в ушах, и способ ее применения
Villarreal et al. Contralateral cochlear labyrinthine concussion without temporal bone fracture: unusual posttraumatic consequence
Igarashi et al. Temporal bone findings in cryptococcal meningitis
Chrbolka et al. Current perspectives of tinnitus and its therapeutic options
KR20200089489A (ko) 골수를 포함하는 감각신경성 난청 또는 이명을 예방 예방 또는 치료하기 위한 약학적 조성물 및 이를 이용한 방법
Sanchez et al. An evaluation of tinnitus treatment
Barreto et al. Intratympanic corticotherapy and tinnitus control after sudden hearing loss
RU2749692C1 (ru) Способ пролонгации действия лекарственного препарата при интратимпанальном введении на структуры внутреннего уха
Larem et al. Tinnitus and Hyperacusis
Hoda et al. Intratympanic dexamethasone injection in chronic tinnitus associated with SNHL
Selvapriya A Study on Efficacy of the Intratympanic Injection of Steroid in the treatment of Subjective Idiopathic Tinnitus
Kotwal et al. HEARING LOSS (BADHIRYA) AND ITS AYURVEDIC MANAGEMENT: A CASE STUDY
RU2637291C1 (ru) Способ реабилитации тугоухости у пациентов
Sano Associated health issues of patients with acquired unilateral hearing loss
Omer Tinnitus and Hyperacusis